Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-05-15
1999-07-06
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 21, A61K 3817
Patent
active
059197579
ABSTRACT:
Aqueous pharmaceutical preparations of G-CSF are disclosed that are stable on storage and a buffer selected from the group consisting of a salt of citrate, maleate, a combination of phosphate and citrate, and arginine; and at least one surfactant.
REFERENCES:
patent: 4992419 (1991-02-01), Woog et al.
patent: 5104651 (1992-04-01), Boone et al.
M. Oh-eda et al.; "Olinked Sugar Chain of Human Granulocyte Colony-stimulating Factor Protects It against Polymerization and Denaturation Allowing It to Retain Its Biological Activity"; The Journal of Biological Chemistry, vol. 265, No. 20, Jul. 15, 1990, pp. 11432-11435.
The Merck Index, 12.sup.th ed., Pub. Merck & Co., Inc. Rahway, NJ, U.S.A. (1996). pp. 627 and 773.
Neupogen.RTM. product package insert, Amgen, Nov. 25, 1992.
Michaelis Uwe
Rudolph Rainer
Winter Gerhard
Woog Heinrich
Boehringer Mannheim GmbH
Spivack Phyllis G.
LandOfFree
Aqueous pharmaceutical preparations of G-CSF with a long shelf l does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aqueous pharmaceutical preparations of G-CSF with a long shelf l, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aqueous pharmaceutical preparations of G-CSF with a long shelf l will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-899030